Profile
Xin Zhong Wang worked as an Associate Director at MedImmune LLC from 2011 to 2014.
He then worked as a Director at Merck Research Laboratories Massachusetts LLC from 2014 to 2017.
From 2017 to 2021, he served as the Chief Scientific Officer & Senior Vice President at CStone Pharmaceuticals Co. Ltd. Prior to his career in the pharmaceutical industry, he earned an undergraduate degree from Nankai University in 1983 and a doctorate degree from The Ohio University in 1993.
Former positions of Xin Zhong Wang
| Companies | Position | End |
|---|---|---|
| CSTONE PHARMACEUTICALS | Chief Tech/Sci/R&D Officer | 2021-02-28 |
Merck Research Laboratories Massachusetts LLC
Merck Research Laboratories Massachusetts LLC Pharmaceuticals: MajorHealth Technology Discovers, develops, and markets a broad range of human and animal health products | Director/Board Member | 2017-05-31 |
MedImmune LLC
MedImmune LLC Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Corporate Officer/Principal | 2013-12-31 |
Training of Xin Zhong Wang
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
MedImmune LLC
MedImmune LLC Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
The Ohio University
The Ohio University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Nankai University
Nankai University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Merck Research Laboratories Massachusetts LLC
Merck Research Laboratories Massachusetts LLC Pharmaceuticals: MajorHealth Technology Discovers, develops, and markets a broad range of human and animal health products | Health Technology |
CStone Pharmaceuticals Co. Ltd.
CStone Pharmaceuticals Co. Ltd. Pharmaceuticals: MajorHealth Technology Develops therapeutic treatments for oncology, cardiovascular diseases, rheumatoid arthritis, hematology and autoimmune diseases | Health Technology |
- Stock Market
- Insiders
- Xin Zhong Wang
















